Trial reportDiabetic medicine : a journal of the British Diabetic Association2026
Testing the feasibility of an intermittent low-energy diet in women with gestational diabetes.
Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05344066 (MIDDAS-GDM), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
MIDDAS-GDM: A Two-Arm Randomised Feasibility Protocol Trial of an Intermittent Low-Energy Diet (ILED) in Women With Gestational Diabetes and Obesity in Greater Manchester
Who cites it
1 citing paper in PubMed.
- Testing the feasibility of an intermittent low-energy diet in women with gestational diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimsThe study aimed to assess feasibility, acceptability and safety of an ILED in a randomised controlled trial of ILED vs. best NHS care healthy diet and exercise advice in women with Gestational Diabetes Mellitus (GDM) with body mass index ≥27.5 kg/m
methodsParticipants were randomised (1:1) to receive an ILED (1000 kcal on two non-consecutive days of the week with 5 days/week of best NHS care healthy diet and exercise advice) or best NHS care healthy diet and exercise advice 7 days/week from recruitment (24-30 weeks gestation) until delivery (BNC). Primary outcomes were uptake, retention and adherence to the interventions. Maternal and neonatal safety outcomes were explored, and secondary outcomes assessed fidelity of the delivery of the intervention and completeness of study data across all trial participants.
resultsParticipants were randomised to ILED (n = 14) or BNC (n = 12) and 73% (n = 19; ILED n = 10, BNC n = 9) received their allocated intervention. There was low study retention (58%; ILED n = 7; BNC n = 8) and low adherence to the ILED median (IQR) 37% (8%-50%) out of prescribed days; however, the study achieved a feasible uptake rate (31%; n = 26). There were no adverse events specifically related to the ILED.
conclusionOur findings suggest that ILED may not be feasible in the third trimester in people with GDM. Future research should explore alternative interventions and interventions earlier in pregnancy for the prevention and management of GDM. TRIAL REGISTRATION NUMBER: NCT05344066.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.